1.Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
2. Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
3. Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter's Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
4. Market Dynamics
4.1 Drivers
4.1.1 Decrease in the recovery time after surgery
4.1.2 Reduction in the cost of newly invented drugs
4.1.3 Development of new sedative seven anaesthetic drugs
4.1.4 Increasing number of surgeries
4.2 Restraints
4.2.1 Risk of adverse reactions to anaesthesia drugs
4.2.2 Lack of skilled anaesthetists to administer the drugs
4.2.3 Risk of side effects of anaesthesia drugs
4.3 Opportunities
4.3.1 Increase in M&A
4.3.2 Growing focus on developing anaesthetics for new ROA
4.4 Challenges
4.4.1 Lack of skilled anesthesiologists
4.4.2 Drug shortages coupled with the fiscal cliff
4.4.3 Side effects coupled with product recalls
5. The Middle East & Africa Anesthesia Drugs Market - By Type
5.1 General Anesthesia
5.2 Spinal Anesthesia
5.3 Interscalene block
5.4 IV Regional Anesthesia
5.5 Local Anesthesia
5.6 Peripheral Nerve Block
5.7 Saddle Block Anesthesia
6. The Middle East & Africa Anesthesia Drugs Market-By Routes of Administration
6.1 Inhalation
6.2 Injection
7. The Middle East & Africa Anesthesia Drugs Market - By Country
7.1.Introduction
7.2. Middle East
7.3 Africa
8. The Middle East & Africa Anesthesia Drugs Market - Company Profiles
8.1 Mylan N.V.
8.2 Hikma Pharmaceuticals PLC
8.3 Fresenius Kabi
8.4 B. Braun
8.5 Aspen
8.6 AbbVie
8.7 Baxter
8.8 Hospira
8.9 Abbott
8.10 Piramal
8.11 AstraZeneca
8.12 Roche
8.13 Novartis
8.14 Pfizer
8.15 Boehringer Ingelheim
9. The Middle East & Africa Anesthesia Drugs Market - Competitive Landscape
9.1 Market Share Analysis
9.2 Strategies Adopted by top companies
9.3 Mergers, Acquisitions, Collaborations & Agreements
10. Market Insights
10.1 Insights of Industry Experts
10.2 Investment Opportunities
10.3 Analyst Opinion
11. Appendix
11.1 List of Tables
11.2 List of Figures
